We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bank of America
BAC
$435B
| $346M | 0.58% |
14,558,586
+9,516
| +0.1% | +$225K |
|
27
Merck
MRK
$322B
| $343M | 0.57% |
4,645,173
+295,042
| +7% | +$22.2M |
|
28
Coca-Cola
KO
$377B
| $336M | 0.56% |
7,529,619
+430,705
| +6% | +$19.8M |
|
29
Netflix
NFLX
$299B
| $333M | 0.56% |
7,311,140
+497,640
| +7% | +$21.2M |
|
30
Walmart Inc
WMT
$885B
| $327M | 0.55% |
8,182,209
+306,801
| +4% | +$12.6M |
|
31
Abbott
ABT
$183B
| $315M | 0.53% |
3,447,528
+99,306
| +3% | +$8.98M |
|
32
Salesforce
CRM
$151B
| $310M | 0.52% |
1,652,747
+144,461
| +10% | +$24.3M |
|
33
Chevron
CVX
$392B
| $308M | 0.51% |
3,450,076
+36,793
| +1% | +$3.29M |
|
34
Pfizer
PFE
$143B
| $304M | 0.51% |
9,792,100
+483,484
| +5% | +$16.4M |
|
|
35
AbbVie
ABBV
$443B
| $297M | 0.5% |
3,020,311
+700,976
| +30% | +$61.7M |
|
36
Costco
COST
$422B
| $272M | 0.45% |
895,741
+66,753
| +8% | +$20.3M |
|
37
McDonald's
MCD
$192B
| $270M | 0.45% |
1,465,266
+17,856
| +1% | +$3.27M |
|
38
Accenture
ACN
$102B
| $264M | 0.44% |
1,227,333
+78,464
| +7% | +$14.8M |
|
39
Amgen
AMGN
$208B
| $264M | 0.44% |
1,117,285
+80,302
| +8% | +$18.3M |
|
40
Eli Lilly
LLY
$1.02T
| $255M | 0.43% |
1,551,146
+99,105
| +7% | +$15.2M |
|
41
American Tower
AMT
$80.8B
| $247M | 0.41% |
956,407
+50,502
| +6% | +$12.5M |
|
42
Thermo Fisher Scientific
TMO
$213B
| $240M | 0.4% |
662,230
+29,799
| +5% | +$9.99M |
|
43
Bristol-Myers Squibb
BMY
$133B
| $238M | 0.4% |
4,055,862
+87,029
| +2% | +$5.21M |
|
44
Texas Instruments
TXN
$252B
| $236M | 0.39% |
1,858,502
+59,651
| +3% | +$6.96M |
|
45
NextEra Energy
NEE
$181B
| $232M | 0.39% |
3,857,324
+121,648
| +3% | +$7.28M |
|
46
Nike
NKE
$61.9B
| $229M | 0.38% |
2,335,586
+151,960
| +7% | +$14M |
|
47
Oracle
ORCL
$374B
| $227M | 0.38% |
4,115,150
+243,700
| +6% | +$12.9M |
|
48
Broadcom
AVGO
$1.85T
| $227M | 0.38% |
7,195,700
+348,370
| +5% | +$9.75M |
|
49
Medtronic
MDT
$109B
| $227M | 0.38% |
2,473,232
+88,436
| +4% | +$8.48M |
|
50
Union Pacific
UNP
$174B
| $221M | 0.37% |
1,309,759
+61,917
| +5% | +$9.92M |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.